Related Experiment Video
Updated: Jun 11, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Novel, likely pathogenic variant in ATP7A associated with Menkes disease diagnosed with ultrarapid genome sequencing
Amy Backal1, Milen Velinov1, Jazmin Garcia1
1Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Abstract:
Menkes disease is a multisystem disorder caused by disturbances in copper absorption and metabolism. This lethal neurodegenerative disease presents with fine, 'kinky' hair, connective tissue dysfunction and developmental regression after 2-3 months of age. The primary variant associated with Menkes is in the ATP7A gene with X-linked recessive inheritance. Historically, the diagnosis of Menkes has relied on clinical signs and symptoms, but as the disease has varying levels of severity and presentation, it can take months to diagnose and treat. Emerging technology for ultrarapid genome sequencing offers a DNA-based route of diagnosis with preliminary results in hours, allowing for earlier discovery and treatment of Menkes with the potential for better long-term outcomes. Ultrarapid whole genome sequencing identified a novel, likely pathogenic, frameshift variant in the ATP7A gene consistent with a diagnosis of Menkes disease. The clinical manifestations and pathophysiology of this disorder, as well as a rapid DNA-based diagnosis, are described in this case.
Insights
Menkes disease, a neurodegenerative disorder affecting copper metabolism, can now be diagnosed rapidly using ultrarapid whole genome sequencing. This DNA-based approach identifies ATP7A gene variants, enabling earlier treatment for better outcomes.
Area of Science:
- Genetics
- Neurodegenerative Diseases
- Biochemistry
Background:
- Menkes disease is a severe X-linked neurodegenerative disorder impacting copper metabolism.
- Clinical diagnosis is often delayed due to variable presentation and reliance on symptoms like kinky hair and developmental regression.
- The ATP7A gene is primarily implicated in Menkes disease.
Purpose of the Study:
- To highlight the potential of ultrarapid whole genome sequencing for timely Menkes disease diagnosis.
- To describe a case of Menkes disease diagnosed rapidly via whole genome sequencing.
- To emphasize the clinical manifestations and pathophysiology of Menkes disease.
Main Methods:
- Ultrarapid whole genome sequencing was employed for diagnosis.
- Genetic analysis focused on identifying variants in the ATP7A gene.
- Clinical data and pathophysiology were reviewed.
Main Results:
- A novel, likely pathogenic, frameshift variant in the ATP7A gene was identified.
- The genetic finding was consistent with a diagnosis of Menkes disease.
- Preliminary diagnostic results were obtained within hours.
Conclusions:
- Ultrarapid whole genome sequencing offers a significantly faster diagnostic pathway for Menkes disease compared to traditional methods.
- Early diagnosis through genetic sequencing can lead to earlier intervention and potentially improved patient outcomes.
- This case underscores the utility of advanced genomic technologies in diagnosing rare genetic disorders.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
ATP Synthase: Mechanism
Single Nucleotide Polymorphisms-SNPs
ATP Synthase: Structure